ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.980
+0.500 (33.78%)
At close: Jul 14, 2025, 4:00 PM
1.980
0.00 (0.00%)
After-hours: Jul 14, 2025, 6:12 PM EDT
ImmunoPrecise Antibodies Employees
As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.
Employees
101
Change (1Y)
-1
Growth (1Y)
-0.98%
Revenue / Employee
$164,169
Profits / Employee
-$319,781
Market Cap
90.61M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 101 | -1 | -0.98% |
Apr 30, 2023 | 102 | 17 | 20.00% |
Apr 30, 2022 | 85 | 12 | 16.44% |
Apr 30, 2021 | 73 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IPA News
- 10 hours ago - ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 7 days ago - ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - Business Wire
- 11 days ago - ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data - Business Wire
- 20 days ago - ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology - Business Wire
- 4 weeks ago - AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies - Business Wire
- 5 weeks ago - ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery - Business Wire
- 7 weeks ago - ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Business Wire
- 7 weeks ago - ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference - Business Wire